CYTOMX THERAPEUTICS INC. - COMMON STOCK

CytomX Therapeutics to Present Preclinical Data for Conditionally Activated Interferon Alpha-2b at the SITC 2023 Annual Meeting

30 أكتوبر 2023 07:00:00 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months Low: CYTOMX THERAPEUTICS INC. - COMMON STOCK

27 أكتوبر 2023 09:43:47 بحسب NetDania Notify

NetDania - New 12 months Low: CYTOMX THERAPEUTICS INC. - COMMON STOCK

26 أكتوبر 2023 08:45:02 بحسب NetDania Notify

CytomX Therapeutics Presents Preclinical Profile of EpCAM-directed Antibody Drug Conjugate CX-2051 at 2023 World ADC Conference

18 أكتوبر 2023 15:30:00 بحسب Nasdaq GlobeNewswire

CytomX Therapeutics to Present at Upcoming September Investor Conferences

05 سبتمبر 2023 15:05:00 بحسب Nasdaq GlobeNewswire

CytomX Therapeutics to Present at the H.C. Wainwright Immune Cell Engager Virtual Conference

10 أغسطس 2023 15:05:00 بحسب Nasdaq GlobeNewswire

CytomX Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update

08 أغسطس 2023 15:15:00 بحسب Nasdaq GlobeNewswire

CytomX Therapeutics to Report Second Quarter 2023 Financial Results on August 8, 2023

01 أغسطس 2023 07:00:02 بحسب Nasdaq GlobeNewswire

CytomX Therapeutics Announces New Employment Inducement Grants

20 يوليو 2023 08:00:00 بحسب Nasdaq GlobeNewswire

CytomX Therapeutics Appoints Yu-Waye (Wayne) Chu, M.D., as Chief Medical Officer

17 يوليو 2023 07:00:01 بحسب Nasdaq GlobeNewswire

CytomX Therapeutics Announces $30 Million Private Placement from BVF Partners L.P.

30 يونيو 2023 07:00:00 بحسب Nasdaq GlobeNewswire

CytomX Therapeutics to Present at the Jefferies Healthcare Conference

01 يونيو 2023 15:05:00 بحسب Nasdaq GlobeNewswire

CytomX Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update

09 مايو 2023 15:15:00 بحسب Nasdaq GlobeNewswire

CytomX Therapeutics to Report First Quarter 2023 Financial Results on May 9, 2023

01 مايو 2023 15:01:00 بحسب Nasdaq GlobeNewswire

CytomX Therapeutics to Present at the H.C. Wainwright BioConnect Investor Conference at NASDAQ

25 أبريل 2023 15:05:01 بحسب Nasdaq GlobeNewswire

CytomX Therapeutics Reports Full Year 2022 Financial Results and Provides Business Update

27 مارس 2023 15:15:00 بحسب Nasdaq GlobeNewswire

CytomX Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results on March 27, 2023

22 مارس 2023 18:23:33 بحسب Nasdaq GlobeNewswire

CytomX Therapeutics to Present at Upcoming March Investor Conferences

28 فبراير 2023 15:05:01 بحسب Nasdaq GlobeNewswire

CytomX Therapeutics Announces Milestone Achievement in Probody® T-Cell Engaging Bispecific (TCB) Collaboration with Astellas

26 يناير 2023 06:00:00 بحسب Nasdaq GlobeNewswire

CytomX Therapeutics to Present at the B. Riley Securities Virtual Annual Oncology Investor Conference

17 يناير 2023 15:05:00 بحسب Nasdaq GlobeNewswire